A new multi-phase clinical trial on rapamycin aims to establish safe dosing for anti-aging, bridging the gap between off-label use and scientific validation in longevity medicine. Recent advancements ...
Analytical exploration of how geroscience, epigenetic reprogramming, and AI-driven therapies are converging to extend healthspan, with insights on clinical trials, societal impacts, and future trends....
